Stephan Christgau
Investment Director, Novo Seeds
Immunology
Acesion Pharma
Denmark
Biography
Prior to joining Novo Seeds, Dr. Christgau was Executive Vice President and Chief Operating Officer at Osteologix where he played a leading role in the development of the company, taking the lead candidate drug through all stages from lead identification to Phase II testing for osteoporosis treatment. Previously, Dr. Christgau has worked in the metabolic bone disease and arthritis areas in Nordic Bioscience and Osteometer Biotech and as a protein chemist in Novo Nordisk A/S.
Research Interest
Immunology
